Communicable episode 36: Finding BALANCE in antibiotic durations—the BALANCE trial
Kathryn Hostettler(European Society of Clinical Microbiology and Infectious Diseases), Angela Huttner(University Hospital of Geneva), Rob Fowler(University of Toronto), Erin K. McCreary(University of Pittsburgh), Nick Daneman(St. Joseph’s Healthcare Hamilton)
Cited by 0
Related Papers
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
|Clinical Microbiology and Infection|2019|263
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
|Journal of Antimicrobial Chemotherapy|2015|262